16322682

Source:http://linkedlifedata.com/resource/pubmed/id/16322682

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:16322682	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:16322682	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:16322682	lifeskim:mentions	umls-concept:C0278883	lld:lifeskim
pubmed-article:16322682	lifeskim:mentions	umls-concept:C2003941	lld:lifeskim
pubmed-article:16322682	lifeskim:mentions	umls-concept:C0599894	lld:lifeskim
pubmed-article:16322682	lifeskim:mentions	umls-concept:C1512954	lld:lifeskim
pubmed-article:16322682	lifeskim:mentions	umls-concept:C1521840	lld:lifeskim
pubmed-article:16322682	pubmed:issue	12	lld:pubmed
pubmed-article:16322682	pubmed:dateCreated	2006-2-7	lld:pubmed
pubmed-article:16322682	pubmed:abstractText	This paper reports the development and application of intralesional targeted alpha therapy (TAT) for melanoma, being the first part of a program to establish a new systemic therapy.	lld:pubmed
pubmed-article:16322682	pubmed:commentsCorrections	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16322682	pubmed:language	eng	lld:pubmed
pubmed-article:16322682	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16322682	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:16322682	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16322682	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16322682	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16322682	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16322682	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16322682	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:16322682	pubmed:month	Dec	lld:pubmed
pubmed-article:16322682	pubmed:issn	1538-4047	lld:pubmed
pubmed-article:16322682	pubmed:author	pubmed-author:LiYongY	lld:pubmed
pubmed-article:16322682	pubmed:author	pubmed-author:AllenBarry...	lld:pubmed
pubmed-article:16322682	pubmed:author	pubmed-author:ThompsonJohn...	lld:pubmed
pubmed-article:16322682	pubmed:author	pubmed-author:GrahamPeterP	lld:pubmed
pubmed-article:16322682	pubmed:author	pubmed-author:ReisfeldRalph...	lld:pubmed
pubmed-article:16322682	pubmed:author	pubmed-author:RajaChandC	lld:pubmed
pubmed-article:16322682	pubmed:author	pubmed-author:RizviSyedS	lld:pubmed
pubmed-article:16322682	pubmed:author	pubmed-author:TsuiWendyW	lld:pubmed
pubmed-article:16322682	pubmed:author	pubmed-author:KearsleyJohnJ	lld:pubmed
pubmed-article:16322682	pubmed:issnType	Print	lld:pubmed
pubmed-article:16322682	pubmed:volume	4	lld:pubmed
pubmed-article:16322682	pubmed:owner	NLM	lld:pubmed
pubmed-article:16322682	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:16322682	pubmed:pagination	1318-24	lld:pubmed
pubmed-article:16322682	pubmed:dateRevised	2006-11-15	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:meshHeading	pubmed-meshheading:16322682...	lld:pubmed
pubmed-article:16322682	pubmed:year	2005	lld:pubmed
pubmed-article:16322682	pubmed:articleTitle	Intralesional targeted alpha therapy for metastatic melanoma.	lld:pubmed
pubmed-article:16322682	pubmed:affiliation	Centre For Experimental Radiation Oncology, St. George Hospital, Kogarah, NSW 2217, Australia. b.allen@unsw.edu.au	lld:pubmed
pubmed-article:16322682	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:16322682	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:16322682	pubmed:publicationType	Comparative Study	lld:pubmed
pubmed-article:16322682	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:16322682	pubmed:publicationType	Clinical Trial, Phase I	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16322682	lld:pubmed